Skip to main content

Home/ Cancer/ Group items tagged oncology

Rss Feed Group items tagged

Matti Narkia

Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxyg... - 0 views

  •  
    Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
    Chen Z, Zhang X, Li M, Wang Z, Wieand HS, Grandis JR, Shin DM.
    Clin Cancer Res. 2004 Sep 1;10(17):5930-9.
    PMID: 15355926
Matti Narkia

Integrative Oncology: Donald Abrams and Andrew Weil - Oxford University Press - 0 views

  •  
    Integrative Oncology
    Donald Abrams and Andrew Weil
    SBN13: 9780195309447
    ISBN10: 0195309448
    Hardback, 624 pages
    Nov 2008, In Stock

Matti Narkia

Oncology Journals - Guide to Internet Resources for Cancer - 0 views

  •  
    Cancer Related Medical Journals
Matti Narkia

List of Cancer-related Medical Journals at Cancer Spectrum: Journals - 0 views

  •  
    A List of Cancer-related Medical Journals
Matti Narkia

Journal of the National Cancer Institute - JNCI Cancer Spectrum - 0 views

  •  
    Medical Journal (cancer related)
Matti Narkia

The Lancet Oncology - 0 views

  •  
    Medical Journal (cancer related)
Matti Narkia

Head and Neck Cancer: An Expert Interview With Dr. Roger B. Cohen - 0 views

  •  
    Innovations in the Treatment of Patients With Head and Neck Cancer: An Expert Interview With Dr. Roger B. Cohen
Matti Narkia

Curative Brachytherapy for Recurrent/Residual Tongue Cancer - Entrez PubMed - 0 views

  •  
    Ayukawa F, Shibuya H, Yoshimura RI, Watanabe H, Miura M.
    Curative Brachytherapy for Recurrent/Residual Tongue Cancer.
    Strahlenther Onkol. 2007 Mar;183(3):133-137.
    PMID: 17340071 [PubMed - as supplied by publisher]
Matti Narkia

Chemokines and squamous cancer of the head and neck: targets for therapeutic interventi... - 0 views

  •  
    Yeudall WA, Miyazaki H.
    Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention?
    Expert Rev Anticancer Ther. 2007 Mar;7(3):351-60.
    PMID: 17338654 [PubMed - in process]
Matti Narkia

PLoS Medicine - A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor... - 0 views

  •  
    Li H, Stampfer MJ, Hollis JBW, Mucci LA, Gaziano JM, et al. (2007)
    A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer.
    PLoS Med 4(3): e103
    doi:10.1371/journal.pmed.0040103
Matti Narkia

Extending the Good Diet, Good Health Paradigm: Modulation of Breast Cancer Resistance P... - 0 views

  •  
    Wang M.
    Extending the good diet, good health paradigm: modulation of breast cancer resistance protein (BCRP) by flavonoids.
    Toxicol Sci. 2007 Apr;96(2):203-5.
    PMID: 17407835 [PubMed - in process]
Matti Narkia

Tetrathiomolybdate: Cancer Protocol. The Treatment and Management of Cancer Today. A re... - 0 views

  •  
    If angiogenesis controls cancer growth, what controls angiogenesis? Researchers at the University of Michigan and the University of South Florida believe that the copper status is critical to the function growth factors.
Matti Narkia

Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesi... - 0 views

  •  
    Q. Pan, C. G. Kleer, K. L. van Golen, J. Irani, K. M. Bottema, C. Bias, M. De Carvalho, E. A. Mesri, D. M. Robins, R. D. Dick, G. J. Brewer, and S. D. Merajver
    Copper Deficiency Induced by Tetrathiomolybdate Suppresses Tumor Growth and Angiogenesis
    Canc
Matti Narkia

Cancer Therapy With Tetrathiomolybdate: Antiangiogenesis by Lowering Body Copper-A Revi... - 0 views

  •  
    Brewer GJ, Merajver SD.
    Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review.
    Integr Cancer Ther. 2002 Dec;1(4):327-37. Review.
    PMID: 14664727 [PubMed - indexed for MEDLINE]
Matti Narkia

Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer -- Redman ... - 0 views

  •  
    B. G. Redman, P. Esper, Q. Pan, R. L. Dunn, H. K. Hussain, T. Chenevert, G. J. Brewer, and S. D. Merajver
    Phase II Trial of Tetrathiomolybdate in Patients with Advanced Kidney Cancer
    Clin. Cancer Res., May 1, 2003; 9(5): 1666 - 1672.
Matti Narkia

Hyperthermia Plus Chemotherapy Nearly Doubles Disease-Free Survival Compared to Chemoth... - 0 views

  •  
    BSD Medical Corp. (Amex: BSM ) announced today that the results of a 340 patient randomized Phase III clinical trial testing the benefit of adding hyperthermia therapy to chemotherapy were presented at the annual American Society of Clinical Oncology (ASC
1 - 20 of 31 Next ›
Showing 20 items per page